Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors

Launched by THE UNIVERSITY OF TENNESSEE, KNOXVILLE · Feb 17, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how a personalized exercise program delivered through a smartphone app and a fitness tracker can help cancer survivors become more active and improve their overall health and quality of life. Researchers want to see if using technology like the Fitbit Inspire 3 and the sFitRx app can motivate cancer survivors to exercise more regularly and how that might affect their weight, feelings, and beliefs about exercise.

To join the study, participants need to be at least 18 years old, have a history of stage 0 to III cancer, and have completed their active cancer treatment at least three months prior, among other criteria. Participants will use the app and tracker to follow a tailored exercise plan, and they should expect to be part of a supportive program aimed at helping them lead a healthier lifestyle. This study is not yet recruiting, but it aims to provide valuable insights into how technology can support cancer survivors in their recovery journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant must be at least 18 years of age
• • Participant was previously diagnosed with stage 0-III cancer
• • Participant have had one or more of the cancers of interest (e.g., breast, lung)
• • Participant completed active cancer treatment at least three months prior to enrollment, with the exception of continued maintenance immunotherapy or endocrine therapy
• • Participant possess basic English communication capability
• • Participant do not participate in other health promotion programs
• • Participant is an Android or Apple smartphone owner
• • Participant is willing to participate in mHealth-delivered programs
• • Participant is willing to consent and be randomized
• • Participant has no contraindications to PA participation
• Exclusion Criteria:
• • Participant is currently undergoing chemotherapy or radiation as primary cancer treatment
• • Having any contraindications that might interfere with PA engagement, such as a medical condition and pacemaker implant
• • Plan to relocate or travel for \>two weeks during the study period;
• • Presence of distant metastasis
• • Planning or preparing for surgery as primary treatment or as a reconstruction procedure in the next 3 months
• • Have a stage 4 cancer diagnosis
• • Participant is already engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months
• • An unstable mental condition that would prevent following study protocols
• • Reporting a Physical Activity Readiness Questionnaire (PAR-Q) score that indicates PA may be unsafe
• • Being a prisoner, pregnant, or planning to become pregnant